Work

Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials

Year: 2022

Type: article

Source: Obstetrical & Gynecological Survey

DOI: 10.1097/ogx.0000000000001113

Authors: Jacques Donnez, Hugh S. Taylor, Elizabeth A. Stewart, Linda Bradley, Erica Marsh, David Archer, Ayman Al-Hendy, Felice Petraglia, Nelson Watts, Jean-Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone, Elizabeth Garner

Institutions: Cleveland Clinic, Mayo Clinic, Eastern Virginia Medical School, University of Michigan, University of Chicago, Michigan Medicine, UCLouvain

Language: English

Topic: Uterine Myomas and Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310729076

FWCI:

Cites:

Cited by:

Related to: 10